Raymond Anderson, Director at Monopar Therapeutics (MNPR), sold 646 shares at $111.07 ($72K) on 2026-08-25, disclosed to the SEC on 2026-08-28.
Scheduled sale ($72k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2015-09-02 | $101K | — | Filing → |
| RPTP | SELL | 2015-03-26 | $259K | — | Filing → |
| RPTP | SELL | 2015-01-14 | $106K | — | Filing → |